8-K ·Filed Oct 15, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
This is a routine investor presentation filing with no new material information. Monitor the company's website or subsequent filings for any substantive updates on pipeline or financials.
Latest settled — T+5d
ERNA ▼ -1.20% at T+5d
NEUTRAL call -1.20% · α vs SPY -0.77% · entry $2.09 → $2.07
T+1d
-5.26%
call -5.26% · α -5.69%
$1.98
settled 11d ago
T+5d
-1.20%
call -1.20% · α -0.77%
$2.07
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Ernexa Therapeutics Inc. filed an 8-K on October 15, 2026, disclosing that it made an investor presentation available. The filing contains no financial data, no guidance, and no material operational updates — it is a routine Regulation FD disclosure of a standard investor deck.
Key Facts
- Filed 8-K with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits)
- Investor presentation attached as Exhibit 99.1, dated October 2026
- No financial results, guidance, or material agreements disclosed in the filing text
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- No new operational or financial data to assess company trajectory
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-047287 |
| Document: 0001493152-26-047287-index-headers.html | 0001493152-26-047287 |
| Document: 0001493152-26-047287-index.html | 0001493152-26-047287 |
| Document: 0001493152-26-047287.txt | 0001493152-26-047287 |
13 reports for ERNA
33% Hit rate @ T+5 Went positive at some point 2 of 3 best @ T+20▲ +96.38%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $2.08 | awaiting T+5 | — | $1.94 (−6.51%) |
Oct 15, 2026 11d ago | 8-K | $2.09 $2.07 | ▼ −1.20% | ▼ −0.77% | $1.94 (−7.18%) |
Oct 1, 2026 25d ago | Press Release | $2.96 $2.49 | ▼ −15.88% | ▼ −17.18% | $1.94 (−34.46%) |
Sep 30, 2026 26d ago | Press Release | $3.20 $2.39 | ▼ −25.31% | ▼ −27.23% | $1.94 (−39.37%) |
Sep 16, 2026 5w ago | 8-K | $3.76 $3.62 | ▼ −3.72% | ▼ −4.32% | $1.94 (−48.40%) |
Sep 16, 2026 5w ago | 8-K | $3.76 $3.62 | ▼ −3.72% | ▼ −4.32% | $1.94 (−48.40%) |
Jul 14, 2026 14w ago | Press Release | $6.06 $5.43 | ▼ −10.40% | ▼ −9.10% | $1.94 (−67.99%) |
Jun 26, 2026 17w ago | 8-K | $7.03 $6.44 | ▼ −8.39% | ▼ −9.78% | $1.94 (−72.40%) |
Jun 17, 2026 18w ago | Press Release | $5.89 $6.30 | ▲ +6.96% | ▲ +8.00% | $1.94 (−67.06%) |
May 27, 2026 21w ago | Press Release | $11.14 $8.00 | ▼ −28.19% | ▼ −29.39% | $1.94 (−82.59%) |
Showing 10 of 13
US Market Status
Market Closed — Opens in 4h 13m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers